Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
QGEN
BuyQiagen N.V. · Healthcare · Netherlands · $8.9B · Avg Vol: $128M/d
COMPANY DESCRIPTION
Qiagen N.V. is a global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from biological samples. The company's key products include sample technologies, diagnostic assays, and bioinformatics software used in molecular diagnostics and life sciences research. Qiagen maintains a leading market position through its proprietary consumables, which generate highly recurring revenue streams.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.1B | 2.0B | 2.0B | 2.1B | -0.8% | 2.1B | 2.1B | 2.3B | 3.8% |
| EPS | 2.82 | 1.67 | 0.41 | 2.06 | -10.0% | 1.97 | 2.11 | 2.26 | 4.7% |
| Shares | 204.0M | 204.4M | 205.3M | 206.1M | +1.0% | 206.5M | — | — | — |
| Debt | 1.9B | 1.5B | 1.5B | 1.8B | -1.3% | 1.7B | — | — | — |
| Equity | 3.5B | 3.8B | 3.6B | 3.8B | 2.9% | — | — | — | — |
| Op CF | 715.3M | 459.5M | 673.6M | 654.3M | -2.9% | 654.5M | — | — | — |
| Inv CF | -726.8M | -87.7M | -249.2M | -305.3M | — | — | — | — | — |
| Fin CF | -125.8M | -433.8M | -422.9M | -179.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of QGEN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| QGEN | Qiagen N.V.(you) | $8.9B | 65 | Buy |
| PHG | Koninklijke Philips N.V. | $26.1B | 84 | Strong Buy |
| RDC.DE | Redcare Pharmacy NV | $1.5B | 54 | Hold |
| ARGX | argenx SE | $63.6B | 75 | Buy |
| PHAR | Pharming Group N.V. | $828M | 55 | Hold |
| QURE | uniQure N.V. | $3.4B | 18 | Strong Sell |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.0B | 9 | Strong Sell |
| PRQR | ProQR Therapeutics N.V. | $323M | 30 | Sell |
| ONWD.BR | Onward Medical N.V. | $199M | 4 | Strong Sell |
Peer medians: ROE 3.6% · P/E 39.9x · Gross margin 69.9%